Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis

Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis

Ziqi Ye,1,* Hongying Zhao,2,* Wuyuan Zhou,3 Tao Ye,4 Chong Geng,4 Xiaofeng Li,5 Lei Yuan,6 Mingyu Du,7 Heng Xu,8 Qiang Wang4 1The First Clinical Medical College, Graduate School, Nanjing Medical University, Nanjing, Jiangsu 210000, People’s Republic of China; 2Medical Oncology, Xuzhou Canc...

Full description

Bibliographic Details
Main Authors: Ye Z, Zhao H, Zhou W, Ye T, Geng C, Li X, Yuan L, Du M, Xu H, Wang Q
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:OncoTargets and Therapy
Subjects:
esophageal squamous cell carcinoma
mmp-9
chemotherapy
concurrent radiotherapy
prognosis
Online Access:https://www.dovepress.com/lower-serum-matrix-metalloproteinase9-in-metastatic-patients-with-esop-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/lower-serum-matrix-metalloproteinase9-in-metastatic-patients-with-esop-peer-reviewed-article-OTT

Similar Items